This is a demo store. No orders will be fulfilled.

  1. This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on advanced therapeutics development for neurological disorders, oncology, immunological diseases. Peptide-drug conjugates, targeted antibodies, gene therapy, and cell therapies have also been discussed in this edition. Protein bioprinting, fiber-based c...

    $950.00
  2. The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations include a non-invasive glucose monitoring device, an implant for anterior cruciate ligament regeneration, a brain visualization neurosurgical tool, and a ultraviolet-C l...

    $950.00
  3. This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on development therapeutics for neurological disorders, mainly on drugs that target protein aggregates. A non-invasive brain computer interface (BCI) technology has also been discussed. Immunotherapeutics for cancer and other therapeutic indications have...

    $950.00
  4. 12 Aug 2021  |  North America  |  Market Research

    Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...

    $4,950.00
  5. 03 Aug 2021  |  North America  |  Market Research

    Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021

    A Benchmarking System to Spark Companies to Action – Innovation That Fuels New Deal Flow and Growth Pipelines

    During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...

    $4,950.00
  6. The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations include several cardiac devices, such as AI-enabled cardiac ultrasound imaging, a smart and wireless ECG monitoring device, and a real-time cardiac monitoring device. Th...

    $950.00
  7. This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers innovations in therapeutics development and improvement of adherence for asthma and other obstructive respiratory diseases. It also covers emerging therapeutic modalities for neurological diseases, including orally delivered small molecules, disease modif...

    $950.00
  8. 29 Jun 2021  |  North America  |  Market Research

    Frost Radar™: Digital Operating Rooms, 2020

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Hospitals are under extreme pressure to reduce costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical issues entail finding new methods to reduce human error and improve the efficiency and quality of surgical care. Technology is now available to help hospitals reduce sur...

    $4,950.00
  9. The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations in this issue include a range of novel implantables such as an implantable cardiac monitor, an implantable device for fluid overload management, an implantable for canc...

    $950.00
  10. 23 Jun 2021  |  Global  |  Market Research

    Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021

    A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

    Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

    $4,950.00